Vision and Goals

Meruvax Pharma vision and goals will ensure that we are solidly positioned to continue our mission of discovering, developing, manufacturing and commercializing life-enhancing and life-saving drug molecules to treat people with serious or life-threatening medical conditions. We are investing to achieve the kind of revenue growth necessary to remain a leading company.

 

Our Vision, utilize the science of Pharma and Biotechnology to become a leader in revolutionizing the treatment of patients with cancer, antigen and immunological disorders.

 

Meruvax Pharma is a knowledge based establishment. Our strategy to establish intellectual strength, successfully market our knowledge through contractual research as well as sponsored projects, Pharma and drugs. Also, we are into the environmental services to understand evaluate experiment and design strategies for the environment.

 

Our investment is our knowledge to discover and develop innovative products for healthcare and environment. The ultimate goal is to provide best possible solutions in the field of medicine and environment to enhance the quality of life.

 

We boast of carrying extremely competent professionals on the board as well as in the main scientific work-force. The mandate of the company keeps a gamut of biotechnological activities that are indicators of our diverse strengths in the fields of life sciences, process development, instrumentation and environmental management.

 

Our professional work force carries out sponsored research as well as internally funded project work in specified areas.

 

Our Goals

  • Bringing at least 3 to 5 new molecules into clinical development each year.
  • Bringing at least 6 major new products or indications onto the market each year.
  • Emerging global leader for Clinical Research Organization (CRO) and Generics

Our Guiding Principles and Scientific Excellence

  • Continue to be recognized for our scientific excellence, innovation and integrity
  • Be a leader in translating basic scientific discoveries into novel therapeutics for significant unmet medical needs

Long-Term Investment Planning

  • Manage the business with a primary intent of building sustainable, long-term growth in shareholder value
  • Apply disciplined decision-making in managing our portfolio of R&D investments, and be smart about every dollar we spend in the company

Execution

  • Set aggressive goals with confidence that our employees have the ability and perseverance to achieve them
  • Insist on single point of accountability and on single decision-maker who effectively balance speed and input to successfully deliver results
  • Insist on effective collaborations across disciplines
  • Be thoughtfully opportunistic - innovative and take risks when and where appropriate
  • Recognize that compliance is essential to the success of our business

People and Culture

  • Embrace our unique culture: our commitment to patients, our passion for scientific excellence, and our respect for the contribution of every individual
  • Keep what is the best for patients at the top of our mindsspeed and input to successfully deliver results
  • Hire only the best people and maintain high standards in work management and performance
  • Set high expectations for our leaders
  • Core team of the innovations with accountability and trust.

 

 

Latest News & Events

  • March 22-26, 2015 249th ACS National Meeting & Exposition, Denver, Colorado.
  • April 8-10, 2015 CPhI South east asia, Jakarta International Expo, Jakarta, Indonesia.
  • May 3-7, 2015 3rd International Symposium on Green Chemistry, La Rochelle , France.
  • August 10-15, 2015 45th World Chemistry Congress (IUPAC-2015), BEXCO, Busan, Korea.
  • August 16-20, 2015 250th ACS National Meeting & Exposition, Boston, Massachusetts.
  • March 13-17, 2016 251st ACS National Meeting & Exposition, San Diego, California.
  • August 21-25, 2016 252nd ACS National Meeting & Exposition, Philadelphia, Pennsylvania.
  • April 2-6, 2017 253rd ACS National Meeting & Exposition, San Francisco, California.
  • August 20-24, 2017 254th ACS National Meeting & Exposition, Washington, DC.
Designer handbags black friday christian louboutin black friday dior cyber monday christian louboutin black friday nike kd vii easy money Nike kd vii Easy Money